Company news
Neuropace, Inc. news in 2022
Neuropace, Inc.'s news releases, calls and decks from 2022, newest first.
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 20, 2022
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
November 29, 2022
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
November 7, 2022
NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
November 3, 2022
NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022
October 24, 2022
NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)
October 10, 2022
NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
August 22, 2022
NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update
August 10, 2022
NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery
August 10, 2022
NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022
July 20, 2022
NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference
May 12, 2022
NeuroPace Reports First Quarter 2022 Financial Results
May 11, 2022
NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents
May 3, 2022
NeuroPace to Report First Quarter 2022 Financial Results on May 12, 2022
April 20, 2022
NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results
March 9, 2022
NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference
January 26, 2022
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue
January 10, 2022
Calls in 2022
Decks in 2022
- Investor Presentation (January 2022)
Investor deck · 19 slides · Jan 11, 2022